Volumetric Absorptive Microsampling (VAMS) technology for IGF-1 quantification by automated chemiluminescent immunoassay in dried blood. (February 2020)
- Record Type:
- Journal Article
- Title:
- Volumetric Absorptive Microsampling (VAMS) technology for IGF-1 quantification by automated chemiluminescent immunoassay in dried blood. (February 2020)
- Main Title:
- Volumetric Absorptive Microsampling (VAMS) technology for IGF-1 quantification by automated chemiluminescent immunoassay in dried blood
- Authors:
- Marchand, A.
Roulland, I.
Semence, F.
Audran, M. - Abstract:
- Abstract: For medical diagnostics and anti-doping analyses, insulin-like growth factor 1 (IGF-1) can be measured in serum using automated chemiluminescent immunoassays. The aim of this study was to assess the feasibility of using dried blood instead of serum to measure IGF-1 concentrations with an automated IGF-1 immunoassay and to evaluate if IGF-1 concentrations from dried capillary blood and serum were comparable. Blood samples (venous blood and capillary blood obtained from the arm skin using a device from Seventh Sense Biosystem) were collected with 20 μL Volumetric Absorptive Micro samplers (VAMS) (Mitra®, Neoteryx). These samplers offer the possibility of collecting a fixed volume of blood without perturbation by hematocrit. Starting from dried blood, an aqueous desorption in 0.9% NaCl was efficient to release IGF-1. The solution was directly analyzed on the automated IGF-1 immunoassay. IGF-1 concentrations after extraction from VAMS were lower than in serum (due to the dilution performed for the elution of IGF-1) but measurable for serum concentrations over 50 ng/mL. In addition, IGF-1 on VAMS was stable for at least one month at room temperature. Following adjustment for dilution, serum and dried blood IGF-1 concentrations were of the same order. However lower concentrations were obtained from the capillary blood in particular for high serum concentrations. In conclusion, a micro volume of dried capillary blood could be used to quantify IGF-1 with an automatedAbstract: For medical diagnostics and anti-doping analyses, insulin-like growth factor 1 (IGF-1) can be measured in serum using automated chemiluminescent immunoassays. The aim of this study was to assess the feasibility of using dried blood instead of serum to measure IGF-1 concentrations with an automated IGF-1 immunoassay and to evaluate if IGF-1 concentrations from dried capillary blood and serum were comparable. Blood samples (venous blood and capillary blood obtained from the arm skin using a device from Seventh Sense Biosystem) were collected with 20 μL Volumetric Absorptive Micro samplers (VAMS) (Mitra®, Neoteryx). These samplers offer the possibility of collecting a fixed volume of blood without perturbation by hematocrit. Starting from dried blood, an aqueous desorption in 0.9% NaCl was efficient to release IGF-1. The solution was directly analyzed on the automated IGF-1 immunoassay. IGF-1 concentrations after extraction from VAMS were lower than in serum (due to the dilution performed for the elution of IGF-1) but measurable for serum concentrations over 50 ng/mL. In addition, IGF-1 on VAMS was stable for at least one month at room temperature. Following adjustment for dilution, serum and dried blood IGF-1 concentrations were of the same order. However lower concentrations were obtained from the capillary blood in particular for high serum concentrations. In conclusion, a micro volume of dried capillary blood could be used to quantify IGF-1 with an automated chemiluminescent immunoassay. However, more data are needed to establish specific IGF-1 reference concentrations using dried capillary blood instead of serum. Graphical abstract: Unlabelled Image Highlights: IGF-1 can be quantified from 20 μl of dried blood with IDS-IGF-1 immunoassay. IGF-1 is stable on VAMS for at least 1 month at room temperature. Dilution-adjusted dried capillary blood IGF-1 and serum IGF-1 are of the same order. Dried blood on VAMS slightly underestimated high IGF-1 concentrations. … (more)
- Is Part Of:
- Growth hormone & IGF research. Volume 50(2020)
- Journal:
- Growth hormone & IGF research
- Issue:
- Volume 50(2020)
- Issue Display:
- Volume 50, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 50
- Issue:
- 2020
- Issue Sort Value:
- 2020-0050-2020-0000
- Page Start:
- 27
- Page End:
- 34
- Publication Date:
- 2020-02
- Subjects:
- IGF-1 dosage -- Immunoassay -- Serum -- Capillary blood -- Venous blood -- Dried blood -- Micro sampling
Growth regulators -- Periodicals
Growth -- Regulation -- Periodicals
Somatomedin -- Periodicals
Somatomedins -- Periodicals
Growth Hormone -- Periodicals
Growth Substances -- Periodicals
Croissance -- Régulation -- Périodiques
Croissance -- Régulateurs -- Périodiques
Somatotrophine -- Périodiques
Somatomédine -- Périodiques
Growth -- Regulation
Growth regulators
Electronic journals
Periodicals
Electronic journals
612.4 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10966374 ↗
http://www.growthhormoneigfresearch.com/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/10966374 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/10966374 ↗
http://www.elsevier.com/journals ↗
http://www.harcourt-international.com/journals ↗
http://www.idealibrary.com/cgi-bin/links/toc/ghir ↗
http://www.harcourt-international.com/journals/ghir/ ↗ - DOI:
- 10.1016/j.ghir.2019.12.001 ↗
- Languages:
- English
- ISSNs:
- 1096-6374
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4223.033700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12945.xml